Immuno-Oncology

Team of positive scientists working in chemistry laboratory

CAR T Cell Therapy

Transformative Potential of CART Cell Therapy for Cancer

Chimeric antigen receptor (CAR) T cell therapy is a form of T-cell therapy in which T cells are genetically engineered to express a CAR. CAR

April 21, 2021 No Comments

Immune Checkpoint Inhibitors

Opportunities and Challenges with Adoption of Immuno-Oncology Drugs and Diagnostics

Checkpoint Inhibitor I-O drugs in the market In cancer, immune checkpoint pathways are often activated to inhibit the nascent anti-tumor immune response. Immune checkpoint therapies

March 23, 2021 No Comments